MAPTHON PHARMACEUTICALS PRIVATE LIMITED
MAPTHON PHARMACEUTICALS PRIVATE LIMITED is a JHARKHAND based PRIVATE LIMITED company, Registered at dated 28-SEP-2018 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of MAPTHON PHARMACEUTICALS PRIVATE LIMITED is U74999JH2018PTC011936 and registration number is 011936.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies India. Authorized share capital of MAPTHON PHARMACEUTICALS PRIVATE LIMITED is Rs. 1000000 and its paid up capital is Rs. 1000000. It aspire to serve in NA activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
MAPTHON PHARMACEUTICALS PRIVATE LIMITED has 2 directors DEEPAK GOSWAMI, AMITA MISHRA,
The registered Email address of MAPTHON PHARMACEUTICALS PRIVATE LIMITED is deepakkmrjsr@gmail.com and its registered address is C/O NEHA KUMARI, JNE-8, ROAD NO. 1, RIVER VIEW COLONY, BARODA GHAT, BAGBERA JAMSHEDPUR 831002 JHARKHAND JHARKHAND india 831002.
The current status of MAPTHON PHARMACEUTICALS PRIVATE LIMITED shows as NOT AVAILABLE FOR EFILING
COMPANY BASIC DETAILS
MAPTHON PHARMACEUTICALS PRIVATE LIMITED
NOT AVAILABLE FOR EFILING
U74999JH2018PTC011936
28 SEP 2018
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
1000000
1000000
CONTACT DETAILS
831002
INDIA
C/O NEHA KUMARI, JNE-8, ROAD NO. 1, RIVER VIEW COLONY, BARODA GHAT, BAGBERA JAMSHEDPUR 831002
deepakkmrjsr@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
07572723 | DEEPAK GOSWAMI | Director | 28/09/2018 |
08242857 | AMITA MISHRA | Director | 28/09/2018 |
Details Updated by Companies
Quick Links
- All Registered company of JHARKHAND
- Company Registered in JHARKHAND
- All Registered company of EAST SINGHBHUM in JHARKHAND
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.